{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T21:10:54Z","timestamp":1770066654760,"version":"3.49.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,14]]},"DOI":"10.7759\/cureus.30312","type":"journal-article","created":{"date-parts":[[2022,10,15]],"date-time":"2022-10-15T04:08:15Z","timestamp":1665806895000},"source":"Crossref","is-referenced-by-count":1,"title":["Is It Safe to Do Percutaneous Coronary Intervention in Moderate to Severe Chronic Kidney Disease Patients? A Prospective Cohort Study"],"prefix":"10.7759","author":[{"given":"Yudistira","family":"Santosa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azizah Dhena","family":"Harca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelina","family":"Yuwono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Hermanto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad S","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edwin","family":"Sukmadja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ratna","family":"Soewardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2011.05.010","article-title":"Acute kidney injury network definition of contrast-induced nephropathy in the critically ill: incidence and outcome","volume":"26","author":"Lakhal K","year":"2011","unstructured":"Lakhal K, Ehrmann S, Chaari A, Laissy JP, R\u00e9gnier B, Wolff M, Pajot O. Acute kidney injury network definition of contrast-induced nephropathy in the critically ill: incidence and outcome. J Crit Care. 2011, 26:593-9. 10.1016\/j.jcrc.2011.05.010","journal-title":"J Crit Care"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1590\/1677-5449.200161","article-title":"Creatinine level variation in patients subjected to contrast-enhanced tomography: a meta-analysis","volume":"20","author":"Moro AB","year":"2021","unstructured":"Moro AB, Strauch JG, Groto AD, Toregeani JF. Creatinine level variation in patients subjected to contrast-enhanced tomography: a meta-analysis. J Vasc Bras. 2021, 20:e20200161. 10.1590\/1677-5449.200161","journal-title":"J Vasc Bras"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4103\/1995-705X.125926","article-title":"Contrast-induced nephropathy","volume":"14","author":"Mohammed NM","year":"2013","unstructured":"Mohammed NM, Mahfouz A, Achkar K, Rafie IM, Hajar R. Contrast-induced nephropathy. Heart Views. 2013, 14:106. 10.4103\/1995-705X.125926","journal-title":"Heart Views"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ehj.2017.12.004","article-title":"Prevention of contrast induced nephropathy by ischemic preconditioning in patients undergoing percutaneous coronary angiography","volume":"70","author":"Elserafy AS","year":"2018","unstructured":"Elserafy AS, Okasha N, Hegazy T. Prevention of contrast induced nephropathy by ischemic preconditioning in patients undergoing percutaneous coronary angiography. Egypt Heart J. 2018, 70:107-11. 10.1016\/j.ehj.2017.12.004","journal-title":"Egypt Heart J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrsc.2015.11.004","article-title":"The prevalence and prognosis of contrast-induced acute kidney injury according to the definition in patients with acute myocardial infarction who underwent primary percutaneous coronary intervention","volume":"13","author":"Kuboyama O","year":"2016","unstructured":"Kuboyama O, Tokunaga T. The prevalence and prognosis of contrast-induced acute kidney injury according to the definition in patients with acute myocardial infarction who underwent primary percutaneous coronary intervention. Clin Trials Regul Sci Cardiol. 2016, 13:29-33. 10.1016\/j.ctrsc.2015.11.004","journal-title":"Clin Trials Regul Sci Cardiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.9721","article-title":"Risk factors associated with contrast-induced nephropathy after primary percutaneous coronary intervention","volume":"12","author":"Kumar D","year":"2020","unstructured":"Kumar D, Liaquat H, Sial JA, et al.. Risk factors associated with contrast-induced nephropathy after primary percutaneous coronary intervention. Cureus. 2020, 12:e9721. 10.7759\/cureus.9721","journal-title":"Cureus"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.36216\/jpd.v5i1.148","article-title":"Faktor resiko contrast induced nephropathy pada pasien yang menjalani prosedur coronary intervention","volume":"5","author":"Kandarini Y","year":"2021","unstructured":"Kandarini Y, Wulandari PJ, Mahadita GW. Faktor resiko contrast induced nephropathy pada pasien yang menjalani prosedur coronary intervention. J Penyakit Dalam Udayana. 2021, 5:20-5. 10.36216\/jpd.v5i1.148","journal-title":"J Penyakit Dalam Udayana"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11092380","article-title":"Optimizing the outcomes of percutaneous coronary intervention in patients with chronic kidney disease","volume":"11","author":"Caracciolo A","year":"2022","unstructured":"Caracciolo A, Scalise RF, Ceresa F, et al.. Optimizing the outcomes of percutaneous coronary intervention in patients with chronic kidney disease. J Clin Med. 2022, 11:2380. 10.3390\/jcm11092380","journal-title":"J Clin Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.29436","article-title":"Adverse impact of chronic kidney disease on clinical outcomes following percutaneous coronary intervention","volume":"97","author":"Bloom JE","year":"2021","unstructured":"Bloom JE, Dinh DT, Noaman S, et al.. Adverse impact of chronic kidney disease on clinical outcomes following percutaneous coronary intervention. Cathet Cardiovasc Intervent. 2021, 97:801-9. 10.1002\/ccd.29436","journal-title":"Cathet Cardiovasc Intervent"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-019-01575-y","article-title":"One-year clinical outcomes in patients with renal insufficiency after contemporary PCI: data from a multicenter registry","volume":"109","author":"Scholz SS","year":"2020","unstructured":"Scholz SS, Lauder L, Ewen S, et al.. One-year clinical outcomes in patients with renal insufficiency after contemporary PCI: data from a multicenter registry. Clin Res Cardiol. 2020, 109:845-56. 10.1007\/s00392-019-01575-y","journal-title":"Clin Res Cardiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4061\/2010\/649164","article-title":"Contrast-induced nephropathy in patients undergoing percutaneous coronary intervention","volume":"2010","author":"Shoukat S","year":"2010","unstructured":"Shoukat S, Gowani SA, Jafferani A, Dhakam SH. Contrast-induced nephropathy in patients undergoing percutaneous coronary intervention. Cardiol Res Pract. 2010, 2010:1-12. 10.4061\/2010\/649164","journal-title":"Cardiol Res Pract"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1055\/s-0030-1267860","article-title":"Prevention of contrast-induced nephropathy (CIN) in interventional radiology practice","volume":"27","author":"Gupta RK","year":"2010","unstructured":"Gupta RK, Bang TJ. Prevention of contrast-induced nephropathy (CIN) in interventional radiology practice. Semin Intervent Radiol. 2010, 27:348-59. 10.1055\/s-0030-1267860","journal-title":"Semin Intervent Radiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.116.004122","article-title":"Prevention of contrast-induced renal failure for the interventional cardiologist","volume":"9","author":"Chau CH","year":"2016","unstructured":"Chau CH, Williams DO. Prevention of contrast-induced renal failure for the interventional cardiologist. Circ Cardiovasc Intervent. 2016, 9:e004122. 10.1161\/CIRCINTERVENTIONS.116.004122","journal-title":"Circ Cardiovasc Intervent"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001038","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Lawton JS","year":"2022","unstructured":"Lawton JS, Tamis-Holland JE, Bangalore S, et al.. 2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022, 145:e18. 10.1161\/CIR.0000000000001038","journal-title":"Circulation"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0107602","article-title":"Do intravenous N-acetylcysteine and sodium bicarbonate prevent high osmolal contrast-induced acute kidney injury? A randomized controlled trial","volume":"9","author":"Inda-Filho AJ","year":"2014","unstructured":"Inda-Filho AJ, Caixeta A, Manggini M, Schor N. Do intravenous N-acetylcysteine and sodium bicarbonate prevent high osmolal contrast-induced acute kidney injury? A randomized controlled trial. PLoS One. 2014, 9:e107602. 10.1371\/journal.pone.0107602","journal-title":"PLoS One"},{"key":"ref16","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","author":"Willis K","year":"2013","unstructured":"Willis K, Cheung M, Slifer S. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013, 3:1-150.","journal-title":"Kidney Int Suppl"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.050686","article-title":"Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options","volume":"143","author":"Jankowski J","year":"2021","unstructured":"Jankowski J, Floege J, Fliser D, B\u00f6hm M, Marx N. Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options. Circulation. 2021, 143:1157-72. 10.1161\/CIRCULATIONAHA.120.050686","journal-title":"Circulation"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.014672","article-title":"Contrast-induced nephropathy","volume":"132","author":"Wichmann JL","year":"2015","unstructured":"Wichmann JL, Katzberg RW, Litwin SE, et al.. Contrast-induced nephropathy. Circulation. 2015, 132:1931-6. 10.1161\/CIRCULATIONAHA.115.014672","journal-title":"Circulation"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.045009","article-title":"ISCHEMIA-CKD: contemporary randomized clinical data at last","volume":"142","author":"Levine GN","year":"2020","unstructured":"Levine GN, Umair Khalid M. ISCHEMIA-CKD: contemporary randomized clinical data at last. Circulation. 2020, 142:520-2. 10.1161\/CIRCULATIONAHA.120.045009","journal-title":"Circulation"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.15420\/ecr.2021.30","article-title":"Coronary artery disease in chronic kidney disease: need for a heart-kidney team-based approach","volume":"16","author":"Shroff GR","year":"2021","unstructured":"Shroff GR, Carlson MD, Mathew RO. Coronary artery disease in chronic kidney disease: need for a heart-kidney team-based approach. Eur Cardiol. 2021, 16:e48. 10.15420\/ecr.2021.30","journal-title":"Eur Cardiol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2009.24.S1.S87","article-title":"The association between kidney function, coronary artery disease, and clinical outcome in patients undergoing coronary angiography","volume":"24","author":"Na KY","year":"2009","unstructured":"Na KY, Kim CW, Song YR, Chin HJ, Chae DW. The association between kidney function, coronary artery disease, and clinical outcome in patients undergoing coronary angiography. J Korean Med Sci. 2009, 24:S87-S94. 10.3346\/jkms.2009.24.S1.S87","journal-title":"J Korean Med Sci"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.12860\/jnp.2014.12","article-title":"Contrast-induced nephropathy; a literature review","volume":"3","author":"Golshahi J","year":"2014","unstructured":"Golshahi J, Nasri H, Gharipour M. Contrast-induced nephropathy; a literature review. J Nephropathol . 2014, 3:51. 10.12860\/jnp.2014.12","journal-title":"J Nephropathol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.4065\/84.2.170","article-title":"Contrast-induced acute kidney injury: specialty-specific protocols for interventional radiology, diagnostic computed tomography radiology, and interventional cardiology","volume":"84","author":"Goldfarb S","year":"2009","unstructured":"Goldfarb S, McCullough PA, McDermott J, Gay SB. Contrast-induced acute kidney injury: specialty-specific protocols for interventional radiology, diagnostic computed tomography radiology, and interventional cardiology. Mayo Clin Proc. 2009, 84:170-9. 10.4065\/84.2.170","journal-title":"Mayo Clin Proc"},{"key":"ref24","article-title":"Contrast-Induced Nephropathy (CIN): Current State of the Evidence on Contrast Media and Prevention of CIN","author":"Eisenberg JM","year":"2007","unstructured":"Eisenberg JM. Contrast-Induced Nephropathy (CIN): Current State of the Evidence on Contrast Media and Prevention of CIN. Agency for Healthcare Research and Quality, Rockville, MD; 2007."},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.5603\/CJ.a2017.0048","article-title":"Association between prophylactic hydration volume and risk of contrast-induced nephropathy after emergent percutaneous coronary intervention","volume":"24","author":"Cui T","year":"2017","unstructured":"Cui T, Zhao J, Bei W, et al.. Association between prophylactic hydration volume and risk of contrast-induced nephropathy after emergent percutaneous coronary intervention. Cardiol J. 2017, 24:660-70. 10.5603\/CJ.a2017.0048","journal-title":"Cardiol J"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.24911\/IJMDC.51-1602705304","article-title":"Role of hydration in contrast-induced nephropathy: a review","volume":"2344","author":"Ajwah I","year":"2020","unstructured":"Ajwah I, Alotaibi M, Alanazi R, et al.. Role of hydration in contrast-induced nephropathy: a review. IJMDC. 2020, 2344:50. 10.24911\/IJMDC.51-1602705304","journal-title":"IJMDC"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.114.001859","article-title":"Safe limits of contrast vary with hydration volume for prevention of contrast-induced nephropathy after coronary angiography among patients with a relatively low risk of contrast-induced nephropathy","volume":"8","author":"Liu Y","year":"2015","unstructured":"Liu Y, Chen JY, Tan N, et al.. Safe limits of contrast vary with hydration volume for prevention of contrast-induced nephropathy after coronary angiography among patients with a relatively low risk of contrast-induced nephropathy. Circ Cardiovasc Interv. 2015, 8:e001859. 10.1161\/CIRCINTERVENTIONS.114.001859","journal-title":"Circ Cardiovasc Interv"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.113.000653","article-title":"Prevention of contrast-induced nephropathy with N-acetylcysteine or sodium bicarbonate in patients with ST-segment-myocardial infarction: a prospective, randomized, open-labeled trial","volume":"7","author":"Thayssen P","year":"2014","unstructured":"Thayssen P, Lassen JF, Jensen SE, et al.. Prevention of contrast-induced nephropathy with N-acetylcysteine or sodium bicarbonate in patients with ST-segment-myocardial infarction: a prospective, randomized, open-labeled trial. Circ Cardiovasc Intervent. 2014, 7:216-24. 10.1161\/CIRCINTERVENTIONS.113.000653","journal-title":"Circ Cardiovasc Intervent"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.1442-18","article-title":"The role of saline and sodium bicarbonate preprocedural hydration to prevent mid-term renal insufficiency in patients with chronic kidney disease undergoing percutaneous coronary intervention","volume":"58","author":"Hagikura A","year":"2019","unstructured":"Hagikura A, Goto K, Takebayashi H, et al.. The role of saline and sodium bicarbonate preprocedural hydration to prevent mid-term renal insufficiency in patients with chronic kidney disease undergoing percutaneous coronary intervention. Intern Med. 2019, 58:1057-65. 10.2169\/internalmedicine.1442-18","journal-title":"Intern Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.5837\/bjc.2015.001","article-title":"Contrast-induced nephropathy in PCI: an evidence-based approach to prevention","volume":"22","author":"Shabbir A","year":"2015","unstructured":"Shabbir A, Kitt J, Ali O. Contrast-induced nephropathy in PCI: an evidence-based approach to prevention. Br J Cardiol. 2015, 22:34. 10.5837\/bjc.2015.001","journal-title":"Br J Cardiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/111773-is-it-safe-to-do-percutaneous-coronary-intervention-in-moderate-to-severe-chronic-kidney-disease-patients-a-prospective-cohort-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:41:36Z","timestamp":1707507696000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/111773-is-it-safe-to-do-percutaneous-coronary-intervention-in-moderate-to-severe-chronic-kidney-disease-patients-a-prospective-cohort-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,14]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.30312","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,14]]}}}